IL-17-producing γδ T cells in the tumor microenvironment promote radioresistance in mice

  • J Clin Invest. 2025 Oct 7:e193945. doi: 10.1172/JCI193945.
Yue Deng  1 Xixi Liu  1 Xiao Yang  1 Wenwen Wei  1 Jiacheng Wang  1 Zheng Yang  1 Yajie Sun  1 Yan Hu  1 Haibo Zhang  2 Yijun Wang  1 Zhanjie Zhang  1 Lu Wen  1 Fang Huang  1 Kunyu Yang  1 Chao Wan  1
Affiliations
  • 1. Cancer Center, Huazhong University of Science and Technology, Wuhan, China.
  • 2. Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China.
Abstract

The immunosuppressive tumor microenvironment (TME) drives radioresistance, but the role of γδ T cells in regulating radiosensitivity remains incompletely understood. In this study, we found that γδ T cell infiltration in the TME substantially increased after radiotherapy and contributed to radioresistance. Depletion of γδ T cells enhanced radiosensitivity. Single-cell RNA Sequencing revealed that γδ T cells in the post-radiotherapy TME were characterized by the expression of Zbtb16, Il23r, and Il17a, and served as the primary source of IL-17A. These γδ T cells promoted radioresistance by recruiting myeloid-derived suppressor cells and suppressing T cell activation. Mechanistically, radiotherapy-induced tumor cell-derived microparticles containing dsDNA activated the cGAS-STING/NF-κB signaling pathway in macrophages, upregulating the expression of the chemokine CCL20, which was critical for γδ T cell recruitment. Targeting γδ T cells and IL-17A enhanced radiosensitivity and improved the efficacy of radiotherapy combined with anti-PD-1 immunotherapy, providing potential therapeutic strategies to overcome radioresistance.

Keywords
Cancer; Immunology; Immunotherapy; Oncology; Radiation therapy.
Products